electroCore Inc. has hired Kelly Benning as senior vice president of Truvaga, a handheld vagus nerve stimulator that uses the company’s technology to quickly and gently activate the vagus nerve. 

Benning has nearly three decades of leadership experience across digital health, artificial intelligence (AI)-enabled technologies, and consumer wellness. She now leads electroCore’s consumer wellness division.

“As an ever-increasing number of people are beginning to be more aware of the link between their lifestyle choices and well-being, wellness has evolved from a niche trend to a fundamental part of the daily lives of many, shifting the focus of the wellness market to a more personalized, consumer-centric dynamic,” Benning said. “It’s important that we meet the demand for consumer-led, lifestyle-based solutions by continuing to innovate and refine our technology, and empowering people to confidently take control of their own well-being. My focus will be on emphasizing electroCore’s commitment to research-based, trustworthy health solutions. I plan to use strategic partnerships to provide more accessibility to those looking to purchase our consumer devices. We’re not just growing a brand; we’re building a movement centered around approachable, personal, and science-backed wellness solutions.”

Benning has successfully brought pioneering digital health products to market, including the first and only U.S. Food and Drug Administration-cleared watch to monitor blood pressure, delivering breakthrough solutions and expertly navigating the commercialization process. Her interest in AI and machine learning has led her to drive continual innovation and consistent market adoption of technology at the intersection of healthcare, data, and consumer experience.

Throughout her career, Benning has worked with numerous consumer retailers, payers, providers, and healthcare enterprises to bring clinically impactful and commercially successful products to market. Before joining electroCore, Benning held executive leadership roles including president at LiveMetric, vice president of Sales at IBM Watson Health, and senior roles at CipherHealth, Savonix, Healthgrades, and National Jewish Health.

Benning earned a bachelor of arts degree in kinesiology and exercise science from the University of Colorado Boulder.

“Bringing a proven and accomplished executive like Kelly to electroCore is the first of several benefits from our accelerating investment to support electroCore’s growth,” electroCOre CEO Dan Goldberger commented. “I am confident Kelly has the right skills to expand our direct-to-consumer strategy.”

electroCore is a commercial stage bioelectronic technology firm striving to improve health and quality of life through innovative non-invasive bioelectronic technologies. The company’s two leading prescription products—gammaCore non-invasive vagus nerve stimulation (nVNS) and Quell neurostimulator—treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its Truvaga products—handheld and personal use nVNS devices using bioelectronic technologies—to promote general wellness and human performance.